Nanopore Sequencing Market to Grow with Advancing Technologies During the Forecast Period
Advancing
biotechnological research is driving the growth in Global Nanopore Sequencing
Market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Nanopore
Sequencing Market
By Product (Instruments v/s Consumables) By Nucleotide Sequenced (DNA v/s RNA) By
Type (Direct Current Sequencing, Exonuclease Sequencing, Synthetic DNA and
Optical Reading Techniques Sequencing, Horizontal Tunnelling Current
Sequencing) By Type of Nanopore (Biological, Solid State, Hybrid) By
Application (Human Genomics, Metagenomics, Plant Sciences, Oncology, Others) By
End User (Clinical Laboratories, Academic & Research Institutes,
Biotechnology Companies, Others) By Region, Competition Forecast &
Opportunities, 2026”, the global nanopore
sequencing market may potentially project an impressive growth in the forecast
period, 2022-2026, with an impressive CAGR on the account of rapidly evolving
biotechnology sector. Research and advancements are carried out to aid various
other sectors of healthcare like pharma, treatment, deducing the advanced
treatment processes, etc. and thereby supporting the growth of the market in
the upcoming five years. Moreover, government schemes, regulatory policies are
aiding the growth of the market with the non-stringy policies. The drug
facilitating and authoritative bodies are actively supporting the latest launch
of the pharmaceutical that are deduced with nanopore sequencing and supporting
the advancement of healthcare industry thus supporting the growth of the global
nanopore sequencing market in the next five years of forecast.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Nanopore Sequencing Market"
https://www.techsciresearch.com/report/nanopore-sequencing-market/7677.html
The global nanopore sequencing market is segmented
by product, nucleotide sequenced, type, type of nanopore, application, end
user, competitional landscape, and regional distribution. Based on nucleotide
sequenced, the market is divided between DNA and RNA. RNA nanopore sequencing
is anticipated to register the fastest growing CAGR in the next five years on
the account of sudden outburst of COVID-19 virus. The demand for the early
vaccines, cure, and precautious measures have driven the market growth at an impressive
CAGR growth rate. The market is expected to register similar exponentially
rising CAGR in the future years. DNA nanopore sequencing is anticipated to
register largest revenue shares of the market in the next five years on the
account of extensive research and technological advancements being carried out
in the subsequent years. Biotechnological institutes and research centers are
rapidly developing and involving extended studies over DNA sequencing and
influencing the market growth in the upcoming five years.
Based on product, the market is further bifurcated
into instruments and consumables. Consumables are the products that are
manufactured through various procedures involving nanopore sequencing. The
market segment for the consumables is anticipated to hold the larger shares of
the market on the account of rapidly rising consumable products in the recent
years. Moreover, the consumable pharmaceutical drugs etc. experienced a surge
in demand that rose due to the COVID-19 virus, thereby supporting the growth of
the global nanopore sequencing market in the next five years. Instruments are
the products and tools that are utilized in the nanopore sequencing processes.
Increase in the research and demand for the treatment along with the evolving
research institutes that are rapidly including academic institutions and
students for the research are aiding the growth of the market segment to
register significant growth in the upcoming five years.
Holding the major shares of the global nanopore
sequencing market are Oxford Nanopore Technologies Ltd, Illumnia, Inc., F
Hoffmann-La Roche AG, 10X Genomics, Inc., Pacific Biosciences of California,
Inc. (PacBio), Agilent Technologies Inc., NabSys, Inc., Sequenom, Inc.,
Quantapore, Inc, INanoBio Inc, Thermo Fischer Scientific, Inc., Cyclomics BV,
CD Genomics, Electronic Biosciences, Inc., Easi-Genomics, among others. Market
players are actively involved in the research and technological development.
The advanced technology has made it possible for the healthcare industry to
provide excellent healthcare services through nanopore sequencing. Further
advancement would aid the market value and brand establishment in the future
five years. New market players may focus on the research and development to
provide options that satisfies the consumer demand as well as benefits the
market players in building their brand value. Other competitive strategies
include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7677
Customers can also request for
10% free customization on this report.
“North America is
anticipated to flourish in the subsequent years vastly on the backbone of
already advanced and technologically sound economies that support world-class
facilitated healthcare industries. Countries like United States and Canada are
expected to register maximum growth. Though, Asia Pacific region with
developing healthcare industry may register the fastest growing CAGR. New
market players may establish their brands if they devote toward extended
research and technological advancements,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based Global management consulting
firm.
“Global Nanopore
Sequencing Market By Product (Instruments v/s Consumables) By Nucleotide
Sequenced (DNA v/s RNA) By Type (Direct Current Sequencing, Exonuclease
Sequencing, Synthetic DNA and Optical Reading Techniques Sequencing, Horizontal
Tunnelling Current Sequencing) By Type of Nanopore (Biological, Solid State,
Hybrid) By Application (Human Genomics, Metagenomics, Plant Sciences, Oncology,
Others) By End User (Clinical Laboratories, Academic & Research Institutes,
Biotechnology Companies, Others) By Region, Competition Forecast &
Opportunities, 2026”,
has evaluated the future growth potential of global Nanopore Sequencing and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global Nanopore Sequencing market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/